The End of Compounded GLP-1s: What Physicians Need to Know https://www.medscape.com/viewarticle/end-compounded-glp-1s-what-physicians-need-know-2025a100063o For the last 2 years, compounded versions of glucagon-like peptide 1 (GLP-1) medications have been big business. Nearly 137 million American adults are eligible to use these costly drugs to treat diabetes and obesity, or for secondary prevention of cardiovascular disease. That’s more than […]
Filed under: General Problems | Leave a Comment »